Literature DB >> 30454670

The Medi-Cal Incentives to Quit Smoking Project: Impact of Statewide Outreach Through Health Channels.

Elisa K Tong1, Susan L Stewart2, Dean Schillinger3, Maya Vijayaraghavan3, Melanie S Dove4, Anna E Epperson5, Cynthia Vela4, Susan Kratochvil6, Christopher M Anderson7, Carrie A Kirby7, Shu-Hong Zhu7, Jessica Safier8, Gordon Sloss9, Neal D Kohatsu10.   

Abstract

INTRODUCTION: Little is known about how incentives may encourage low income smokers to call for quitline services. This study evaluates the impact of outreach through health channels on California Medicaid (Medi-Cal) quitline caller characteristics, trends, and reach. STUDY
DESIGN: Longitudinal study. SETTING/PARTICIPANTS: Medi-Cal quitline callers. INTERVENTION: Statewide outreach was conducted with health providers, Medi-Cal plans (all-household mailings with tracking codes), and public health organizations (March 2012-July 2015). For incentives, Medi-Cal callers could ask for a $20 gift card; in September 2013, callers were offered free nicotine patches. MAIN OUTCOME MEASURES: Caller characteristics were compared with chi-square analyses, joinpoint analysis of call trends was performed accounting for Medi-Cal population growth, referral source among Medi-Cal and non-Medi-Cal callers was documented, and the annual percentage of the population reached who called the Helpline was calculated. Analyses were conducted 2016-2018.
RESULTS: Total Medi-Cal callers were 92,900, a 70% increase from prior annual averages: 12.4% asked for the financial incentive, 17.3% reported the mailing code, and 73.3% received nicotine patches while offered. Among the two thirds of callers who completed counseling, 15.5% asked for the financial incentive, and 13.6% reported the mailing code. A joinpoint analysis showed call trends increased 23% above expected for the Medi-Cal population growth after mailings to providers and members began, and decreased after outreach ended. Annual reach increased from 2.3% (95% CI=2.1, 2.6) in 2011 to peak at 4.5% (95% CI=3.6, 5.3) in 2014. Among subgroups with higher reach rates, some also had higher rates of asking for the financial incentive (African Americans, American Indian), reporting the tracking code (whites), or both (aged 45-64 years). Medi-Cal callers were more likely than non-Medi-Cal callers to report providers (32.3% vs 23.8%) and plans (19.7% vs 1.4%) as their referral source, and less likely to cite media (20.2% vs 44.4%, p<0.001).
CONCLUSIONS: Statewide outreach through health channels incentivizing Medi-Cal members increased the utilization and reach of quitline services. SUPPLEMENT INFORMATION: This article is part of a supplement entitled Advancing Smoking Cessation in California's Medicaid Population, which is sponsored by the California Department of Public Health.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30454670     DOI: 10.1016/j.amepre.2018.07.031

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  3 in total

1.  Health System Implementation of a Tobacco Quitline eReferral.

Authors:  Eve Angeline Hood-Medland; Susan L Stewart; Hien Nguyen; Mark Avdalovic; Scott MacDonald; Shu-Hong Zhu; Antonio Mayoral; Elisa K Tong
Journal:  Appl Clin Inform       Date:  2019-10-02       Impact factor: 2.342

2.  Effects of active referral combined with a small financial incentive on smoking cessation: study protocol for a cluster randomised controlled trial.

Authors:  Xue Weng; Man Ping Wang; Ho Cheung William Li; Yee Tak Derek Cheung; Ching Yin Lau; Antonio Cho Shing Kwong; Vienna Wai Yin Lai; Sophia Siu Chee Chan; Tai Hing Lam
Journal:  BMJ Open       Date:  2020-10-26       Impact factor: 2.692

3.  Factors Associated With Receipt of Smoking Cessation Advice and Assistance by Health Professionals Among Latino and Non-Latino White Smokers With Medicaid Insurance in California.

Authors:  Cindy V Valencia; Melanie Dove; Elisa K Tong
Journal:  JAMA Netw Open       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.